Related Experiment Video
Updated: Aug 15, 2026

09:52
An Implantable System For Chronic In Vivo Electromyography
Published on: April 21, 2020
Achalasia occurring years after acute poliomyelitis
1Department of Medical Clinic, School of Medicine of Ribeirão Preto, University of São Paulo.
Arquivos De Gastroenterologia
|April 1, 1993
Summary
This case study suggests poliomyelitis may cause achalasia, a rare esophageal motility disorder. Further research is needed to explore this potential link between viral infections and achalasia development.
Area of Science:
- Gastroenterology
- Neurology
- Infectious Diseases
Background:
- Idiopathic achalasia is a rare esophageal motility disorder.
- The etiology of achalasia remains largely unknown, with several hypotheses proposed.
- Chagas' disease is a known infectious cause of achalasia.
Observation:
- A 19-year-old female presented with a 4-month history of dysphagia.
- Diagnostic evaluations confirmed idiopathic achalasia.
- The patient had a history of acute poliomyelitis at age three, resulting in leg muscle atrophy.
Findings:
- Clinical, epidemiologic, and serologic tests excluded Chagas' disease.
- The patient's history of poliomyelitis suggests a potential neurological link.
- Poliomyelitis may have caused damage to the dorsal motor nucleus of the vagus nerve, leading to lower esophageal sphincter dysfunction.
Implications:
- This case supports the infective hypothesis for achalasia.
- Poliomyelitis is a potential, previously unrecognized, cause of achalasia.
- Further investigation into viral etiologies of esophageal motility disorders is warranted.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Botulism
Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Esophageal Achalasia
Esophageal achalasia is a chronic neurogenic disorder characterized by impaired relaxation of the lower esophageal sphincter (LES) and absent or ineffective peristalsis in the distal esophagus. This leads to a functional obstruction without a physical blockage, despite significant disruption of esophageal motility.EtiologyAchalasia is caused by degeneration of the myenteric (Auerbach's) plexus, specifically the loss of inhibitory ganglion cells that produce vasoactive intestinal peptide (VIP)...
Pyloric Obstruction
Pyloric obstruction, also referred to as gastric outlet obstruction, is a condition characterized by narrowing or blockage at the pylorus—the muscular valve regulating the flow of stomach contents into the duodenum. When this passage becomes impaired, the stomach cannot effectively empty its contents into the small intestine. This disruption leads to a range of gastrointestinal symptoms, including early satiety, bloating, epigastric pain, postprandial nausea, persistent vomiting, and...

